C4 therapeutics inc.

Other-Pharmaceuticals

CCCC


490 Arsenal Way
Watertown , MA 02472

Executive/
Director

Price

  • Last Close
  • $ 3.92
    $ +0.26 6.96 %
    Jan 3, 2025
  • 52-Week High/Low
  • $11 - $1.18
  • YTD
  • 8.7%

  • Trading Volume
  • 34,331
  • Market Cap Full
  • $ 192.3M
  • Shares Outstanding
  • 49.1M
    Apr 25, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% 6.2% -27.8% -46.8% 44.6% 8.7%
Q2 - - - - 4% 2.3% -68.9% -12.4% -43.2% -
Q3 - - - - 8% 18.3% 16.3% -32.4% -4.2% -
Q4 - - - - 36.6% -24.9% -32.7% 232.4% -40.4% -
J F M A M J J A S O N D
2025 8.7% - - - - - - - - - - -
2024 9.4% 77.7% -25.6% -17.4% -25.9% -7.8% 45.6% -4.2% - - - -21.6%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-3%-82%-4%-36%9%

Earnings

2021 2022 2023
Q1 -0.49 -0.65 -0.71
Q2 -0.51 -0.56 -0.73
Q3 -0.51 -0.65 -0.55
Q4 -0.31 -0.76 -
A -1.8 -2.6 -1.99

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 43.1 48.7 49.1
Jun - 43.2 48.8 49.1
Sep - 48.5 48.9 -
Dec 43 48.6 49 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.4 0.3 5.5 3 -
Total Asset Turnover 0.1 0.1 0.1 0.2 -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 65 -41 -10 35 -
Equity multiplier 0.3 0.4 - -7 -